To identify additional alternative therapy which potentially might be applied for treatment of ALCL patients resistant to ALK inhibitors, we tested the efficacy of different small-molecule inhibitors on growth inhibition of resistant and parental Karpas299 cells (data not shown). This evidence concerns the gene ALK and anaplastic large cell lymphoma.